Indication
Mature B-Cell Non-Hodgkin Lymphoma
1 clinical trial
7 products
Product
ObinutuzumabClinical trial
A Phase I/II, Open-Label, Single-Arm, Two-Part Trial to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of Glofitamab in Monotherapy and in Combination With Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin LymphomaStatus: Recruiting, Estimated PCD: 2027-10-15
Product
RituximabProduct
CarboplatinProduct
GlofitamabProduct
IfosfamideProduct
EtoposideProduct
Tocilizumab